Skip to main content
Top
Published in: Intensive Care Medicine 10/2018

01-10-2018 | What's New in Intensive Care

Declaration of conflicts of interest: a ‘crooked’ line towards scientific integrity

Authors: Laurent Brochard, Brian P. Kavanagh

Published in: Intensive Care Medicine | Issue 10/2018

Login to get access

Excerpt

In 2003, Martin Tobin, as Editor-in-Chief of American Journal of Respiratory and Critical Care Medicine, introduced a policy on conflict of interest (COI) [1]. He expressed that a COI is “…a set of conditions in which professional judgement concerning a primary interest, such as the validity of research, might be influenced by a secondary interest, such as financial gain. The secondary interest is usually not illegitimate in itself, but it becomes a problem when it eclipses the primary interest. …a conflict of interest is a condition, not a behavior—being determined by circumstances, not by outcome. A conflict exists…when judgment might or might be perceived to be influenced… before any actual breach of trust, and irrespective of whether a breach of trust actually occurs”. The readers must know about financial ties with industry for them to determine whether the COI may have biased the presentation of the results: the declaration allows the reader to decide. Many other sources of bias, conscious or unconscious, exist in research but financial COI can be easily identified and quantified (note: the nature of the transaction characterizes a condition, not a behaviour). The International Committee of Medical Journal Editors, which had previously produced the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (1978), started in 2009 to use a common form to declare COI [2]. The principle of this declaration was to maintain “…public trust in the scientific process and the credibility of published articles...” [3]. Many journals had already developed policies regarding COI but the lack of uniformity made that individual authors could report different information to different journals. This was an important and welcome step. Fifteen years later, we ask did this improve integrity of research? …
Literature
1.
go back to reference Tobin MJ (2003) Conflicts of interest and AJRCCM: restating policy and a new form to upload. Am J Respir Crit Care Med 167:1161–1164CrossRef Tobin MJ (2003) Conflicts of interest and AJRCCM: restating policy and a new form to upload. Am J Respir Crit Care Med 167:1161–1164CrossRef
2.
go back to reference Drazen JM, Van der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, Kotzin S, Horton R, Hebert PC, Haug C, Godlee F, Frizelle FA, de Leeuw PW, DeAngelis CD (2009) Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med 361:1896–1897CrossRef Drazen JM, Van der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, Kotzin S, Horton R, Hebert PC, Haug C, Godlee F, Frizelle FA, de Leeuw PW, DeAngelis CD (2009) Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med 361:1896–1897CrossRef
4.
go back to reference Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555CrossRef Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555CrossRef
7.
go back to reference Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ (2006) Patients’ views on financial conflicts of interest in cancer research trials. N Engl J Med 355:2330–2337CrossRef Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ (2006) Patients’ views on financial conflicts of interest in cancer research trials. N Engl J Med 355:2330–2337CrossRef
9.
go back to reference Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290:921–928CrossRef Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290:921–928CrossRef
10.
go back to reference Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325:249CrossRef Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325:249CrossRef
11.
go back to reference Cain DM, Loewenstein G, MD A (2005) The dirt on coming clean: perverse effects of disclosing conflicts of interest. J Leg Stud 34:1–25CrossRef Cain DM, Loewenstein G, MD A (2005) The dirt on coming clean: perverse effects of disclosing conflicts of interest. J Leg Stud 34:1–25CrossRef
12.
go back to reference Rubenfeld GD (2007) The conflict vitae: a CV for the new millennium. Lancet 370:318CrossRef Rubenfeld GD (2007) The conflict vitae: a CV for the new millennium. Lancet 370:318CrossRef
Metadata
Title
Declaration of conflicts of interest: a ‘crooked’ line towards scientific integrity
Authors
Laurent Brochard
Brian P. Kavanagh
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 10/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-018-5358-7

Other articles of this Issue 10/2018

Intensive Care Medicine 10/2018 Go to the issue